The safety profile of subcutaneous allergen immunotherapy in children with asthma in Hangzhou, East China

This retrospective survey showed that properly-conducted SCIT was a safe treatment for children and adolescents with asthma in Hangzhou, East China. Children and patients with moderate asthma may be prone to develop SRs.